Sample product 1

Sample product 1

£10,712

التصنيفات: , , , ,

The Xeno-Free (XF) Bioreactor human Bone Marrow-derived MSC Scale-Up Kits include RoosterBio XF hMSCs, XF RoosterNourish expansion media, and XF RoosterReplenish bioreactor feed. A kit designed for process development with cell and media for 1 x 3L fed-batch hMSC microcarrier based bioreactor run.

Simplified, step by step process recommendations from seed-train to bioreactor expansion are available for multiple bioreactor platforms to ensure no matter the level of bioreactor experience, scientists can quickly and effortlessly generate billions of hMSCs within 8 to 10 days.

An additional kit option for hMSC-EV production includes RoosterCollect EV Pro to seamlessly transition from hMSC production to Exosomes / Extracellular Vesicle (EV) generation.

Intended Use: Research Use Only

المراجعات

لا توجد مراجعات بعد.

كن أول من يقيم “Sample product 1”

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *

منتجات ذات صلة

انتقل إلى أعلى

Hi
Here you can see some frequently asked questions or contact us!

What passage are your cells?

Our human mesenchymal stem/stromal cells (hMSCs) are provided at a population doubling level (PDL) of 8-10 post-mononuclear isolation (Bone Marrow; Equivalent Passage 2) or 14-18 post-isolation from the perivascular region of Wharton’s Jelly (Umbilical Cord; Equivalent Passage 3). Due to variabilities of seeding and harvest densities we characterize our MSC “True Age” in terms of their PDL.

How often should I feed your cells?

A: There is no need to feed cells between passages. Our media is engineered to be a batch culture media, where no media exchange or feed is necessary when following our suggested protocols.

Are your vials sold from pooled donors?

No, we do not pool donors at any time during our production. Master Cell Banks (MCBs) are created from each donor source. Working Cell Banks (WCBs) are produced from our MCBs for general product sales.

What characterization do you provide for your hMSCs?

We characterize our hMSCs by following ISCT criteria: cell identity (surface marker expression), functional potency (angiogenic cytokine and IDO secretion), and trilineage differentiation (adipo-, osteo-, and chondrogenesis). This information is provided to allow customers to choose the optimal hMSC tissue type and donor for their specific application or target indication.